While China Pulls Ahead In Regenerative Medicine Research, Its Loosely Regulated Stem Cell Treatment Centers Raise International Concerns
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's ascendancy as a world power in regenerative medicine has been marked by a rapid-fire increase in the writing of top-level papers in the field for international scientific publications, but also by the appearance of controversial stem cell centers that sometimes offer treatments that have not been tested in clinical trials